Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Italgel, also known historically and legally as Italgelatine, is an Italian private manufacturer of gelatine, hydrolyzed collagen, and collagen peptides used across pharmaceutical, nutraceutical, health, and food applications. The company is headquartered in Santa Vittoria d'Alba, Piedmont, and describes itself as one of the leading producers of gelatine and hydrolyzed collagen globally, with exports to more than 40 countries. In healthcare-related markets, its products are positioned primarily as pharmaceutical-grade excipients and functional protein ingredients for capsules, tablets, vitamin preparations, and related formulations rather than as proprietary therapeutics. The business appears to operate as a mature commercial manufacturing company rather than a drug developer, with capabilities spanning bovine and porcine-derived gelatine products as well as hydrolyzed collagen and instant gelatine solutions. Italgel is relevant to life sciences mainly through supply of pharmaceutical and nutraceutical raw materials.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Italgel.